METTL3, the principal RNA N6-adenosine methyltransferase, is significantly elevated in human hepatocellular carcinoma (HCC) and various solid tumors, correlating with adverse outcomes in patients with HCC. This evidence concerns the gene METTL3 and hepatocellular carcinoma.